AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $307B
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Quarter Return
-14.77%
1 Year Return
+24.17%
3 Year Return
+108.02%
5 Year Return
+184.14%
10 Year Return
+481.49%
AUM
$219B
AUM Growth
+$219B
Cap. Flow
+$9.58B
Cap. Flow %
4.38%
Top 10 Hldgs %
23.52%
Holding
3,484
New
234
Increased
1,638
Reduced
1,111
Closed
231

Sector Composition

1 Technology 25.56%
2 Healthcare 17.57%
3 Financials 12.29%
4 Consumer Discretionary 10.51%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RNAC icon
3451
Cartesian Therapeutics
RNAC
$261M
-110,700
Closed -$136K
RRGB icon
3452
Red Robin
RRGB
$116M
-13,605
Closed -$229K
RSVR icon
3453
Reservoir Media
RSVR
$517M
-13,766
Closed -$135K
RVP icon
3454
Retractable Technologies
RVP
$25.1M
-33,500
Closed -$159K
RYTM icon
3455
Rhythm Pharmaceuticals
RYTM
$6.85B
-44,900
Closed -$517K
SBSW icon
3456
Sibanye-Stillwater
SBSW
$5.36B
-260,000
Closed -$4.22M
SGHT icon
3457
Sight Sciences
SGHT
$213M
-1,788,692
Closed -$20.7M
SLDB icon
3458
Solid Biosciences
SLDB
$427M
-46,700
Closed -$56K
SPRO icon
3459
Spero Therapeutics
SPRO
$116M
-12,934
Closed -$113K
SPRU icon
3460
Spruce Power Holding Corp
SPRU
$25.9M
-96,200
Closed -$191K
SRRK icon
3461
Scholar Rock
SRRK
$3.14B
-28,700
Closed -$370K
STXS icon
3462
Stereotaxis
STXS
$261M
-29,100
Closed -$109K
SYRE icon
3463
Spyre Therapeutics
SYRE
$996M
-21,600
Closed -$50K
TAK icon
3464
Takeda Pharmaceutical
TAK
$47.3B
-251,187
Closed -$3.6M
TCRT icon
3465
Alaunos Therapeutics
TCRT
$4.21M
-213,560
Closed -$139K
TME icon
3466
Tencent Music
TME
$37.8B
-12,095
Closed -$59K
TNXP icon
3467
Tonix Pharmaceuticals
TNXP
$260M
-101,700
Closed -$23K
TS icon
3468
Tenaris
TS
$18.9B
-150,000
Closed -$4.51M
TSAT icon
3469
Telesat
TSAT
$307M
-16,237
Closed -$268K
TSLX icon
3470
Sixth Street Specialty
TSLX
$2.3B
-15,966
Closed -$372K
TXMD icon
3471
TherapeuticsMD
TXMD
$12.8M
-253,200
Closed -$96K
UEIC icon
3472
Universal Electronics
UEIC
$64.8M
-11,552
Closed -$361K
UL icon
3473
Unilever
UL
$155B
-28,129
Closed -$1.28M
URGN icon
3474
UroGen Pharma
URGN
$900M
-24,500
Closed -$213K
VCR icon
3475
Vanguard Consumer Discretionary ETF
VCR
$6.41B
-661
Closed -$202K